FY2029 Earnings Forecast for Passage Bio Issued By Wedbush
Passage Bio, Inc. (NASDAQ:PASG – Free Report) – Equities researchers at Wedbush issued their FY2029 EPS estimates for Passage Bio in a research note issued to investors on Tuesday, March 4th. Wedbush analyst Y. Zhong forecasts that the company will earn ($0.40) per share for the year. Wedbush currently has a “Outperform” rating and a […]
